In recent years, surface-enhanced Raman scattering (SERS) based on metal oxide semiconductors has been an active area of research and development, attracting significant scientific interest. These SERS substrates are known as plasmon-free SERS substrates because they are not based on noble metal nanoparticles but mainly on the defects, structure, and surface morphology of semiconductors to enhance the Raman signal. In this study, we fabricated a SERS substrate based on molybdenum oxide, using reactive DC magnetron sputtering and then used different simple and effective strategies to enhance the Raman signal.
View Article and Find Full Text PDFBackground: Asthma and obstructive sleep apnea (OSA) are common chronic respiratory disorders in children. The relationship between asthma and OSA is bidirectional; these conditions share multiple epidemiological risk factors. Untreated OSA may cause attention deficit hyperactivity disorder (ADHD) symptoms.
View Article and Find Full Text PDFBackground: Obstructive sleep apnea (OSA) is the most common form of respiratory disorders during sleep in children, especially those with severe asthma. However, optimal treatment of asthma might significantly improve OSA severity.
Methods: It was a cohort study including children aged >5 years old and diagnosed with asthma according to GINA (Global Initiative for Asthma).
Obstructive sleep apnea (OSA) is a common disease that is often under-diagnosed and under-treated in all ages. This is due to differences in morphology, diversity in clinical phenotypes, and differences in diagnosis and treatment of OSA in children and adults, even among individuals of the same age. Therefore, a personalized medicine approach to diagnosis and treatment of OSA is necessary for physicians in clinical practice.
View Article and Find Full Text PDFIntroduction: Inhaled corticosteroid (ICS) is the most widely used and effective treatment of asthma. However, some patients do not respond to ICS, which might be due to various genetic factors. Hence, understanding the genetic factors involved in the ICS response could help physicians to individualize their treatment decision and action plans for given patients.
View Article and Find Full Text PDF